We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $412M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-4.98%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$104M
Cap. Flow
+$114M
Cap. Flow %
52.89%
Top 10 Hldgs %
3.25%
Holding
1,960
New
575
Increased
592
Reduced
190
Closed
602

Top Buys

Rank Stock Value
1
PLAB icon
Photronics
PLAB
+$919K
2
ALXO icon
ALX Oncology
ALXO
+$905K
3
EYPT icon
EyePoint Inc
EYPT
+$814K
4
MGNX icon
MacroGenics
MGNX
+$773K
5
CMPS
Compass Pathways
CMPS
+$725K

Top Sells

Rank Stock Value
1
STRO icon
Sutro Biopharma
STRO
+$394K
2
RIOT icon
Riot Platforms
RIOT
+$366K
3
REVG
REV Group
REVG
+$362K
4
TSHA icon
Taysha Gene Therapies
TSHA
+$353K
5
PBYI icon
Puma Biotechnology
PBYI
+$329K

Sector Composition

Rank Sector Weight
1 Healthcare 18.55%
2 Technology 15.83%
3 Industrials 15.4%
4 Financials 12.94%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WIRE
1951
DELISTED
Encore Wire Corp
WIRE
– –
-459
Closed -$121K
MODN
1952
DELISTED
MODEL N, INC.
MODN
– –
-3,723
Closed -$106K
DCPH
1953
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-9,795
Closed -$154K
FUSN
1954
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-349
Closed -$7.44K
SWAV
1955
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-27
Closed -$8.79K
ALPN
1956
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-1,433
Closed -$56.8K
MRNS
1957
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-5,574
Closed -$50.4K
ML
1958
DELISTED
MoneyLion Inc.
ML
– –
-984
Closed -$70.2K
HIBB
1959
DELISTED
Hibbett, Inc. Common Stock
HIBB
– –
-31
Closed -$2.38K
VZIO
1960
DELISTED
VIZIO Holding Corp.
VZIO
– –
-3,595
Closed -$39.3K
75 76 77 78
79

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
T
TOBAM Paris, France $412M AUM 18.33% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return

EntryPoint Capital's Q2 2024 Portfolio in Review

As of Q2 2024, EntryPoint Capital held 1,960 positions worth $215M, up 93% from $112M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

EntryPoint Capital deployed $114M of net new capital in Q2 2024, opening 575 new positions and adding to 592 existing holdings. Its largest new stake was EyePoint Inc: 58,291 shares worth $507K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Oscar Health, an estimated $327K trimmed.

  • EntryPoint Capital's largest Q2 2024 buy was EyePoint Inc: 58,291 shares worth $507K.
  • EntryPoint Capital added most to Photronics in Q2 2024, an estimated $919K increase.
  • EntryPoint Capital's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $327K.
  • EntryPoint Capital fully exited Sutro Biopharma in Q2 2024, selling an estimated $394K.
  • EntryPoint Capital's ten largest holdings make up 3.3% of its $215M portfolio in Q2 2024.
  • EntryPoint Capital opened 575 new positions and closed 602 in Q2 2024.
  • EntryPoint Capital's portfolio value rose 93% quarter-over-quarter to $215M.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.